Can Rigosertib Change the Myelodysplastic Syndromes Treatment Landscape?
source: pixabay.com

Can Rigosertib Change the Myelodysplastic Syndromes Treatment Landscape?

By Lauren Taylor from In The Cloud Copy Onconova Therapeutics, Inc. is a biopharmaceutical company that works to develop new drugs to treat cancer, primarily focusing on myelodysplastic syndromes. Myelodysplastic…

Continue Reading Can Rigosertib Change the Myelodysplastic Syndromes Treatment Landscape?
What’s It Like to Be a Long-Hauler? An Epidemiologist Explains
https://pixabay.com/photos/hospital-room-inside-indoors-2301041/

What’s It Like to Be a Long-Hauler? An Epidemiologist Explains

In early June, PatientWorthy wrote about a group of patients called "long haulers." These people, some healthy and some with pre-existing conditions, experienced extended COVID-19 symptoms, sometimes for months after…

Continue Reading What’s It Like to Be a Long-Hauler? An Epidemiologist Explains

Salk Institute Team Develops the First Insulin-Producing Human Cells That Control Blood Sugar in Type 1 Diabetes

Salk Institute scientists have scored a significant gain in their quest to find a functional treatment for type 1 diabetes. According to an article in Salk News, scientists at the…

Continue Reading Salk Institute Team Develops the First Insulin-Producing Human Cells That Control Blood Sugar in Type 1 Diabetes